GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Other Long-Term Liabilities

Oculis Holding AG (FRA:CR5) Other Long-Term Liabilities : €0.39 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Other Long-Term Liabilities?

Oculis Holding AG's other long-term liabilities for the quarter that ended in Mar. 2024 was €0.39 Mil.

Oculis Holding AG's quarterly other long-term liabilities increased from Sep. 2023 (€0.39 Mil) to Dec. 2023 (€0.40 Mil) but then declined from Dec. 2023 (€0.40 Mil) to Mar. 2024 (€0.39 Mil).

Oculis Holding AG's annual other long-term liabilities increased from Dec. 2021 (€109.07 Mil) to Dec. 2022 (€124.08 Mil) but then declined from Dec. 2022 (€124.08 Mil) to Dec. 2023 (€0.40 Mil).

Oculis Holding AG Other Long-Term Liabilities Historical Data

The historical data trend for Oculis Holding AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Other Long-Term Liabilities Chart

Oculis Holding AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
- - - -

Oculis Holding AG Quarterly Data
Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oculis Holding AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Oculis Holding AG Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Oculis Holding AG (FRA:CR5) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Other Long-Term Liabilities
Comparable Companies
LXRX MGNX ICVX SPRY CHRS TERN AURA ERAS NAUT MLYS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
OCS:USA OCS:Iceland
Address
Bahnhofstrasse 7, Zug, CHE, 6300
Website
https://www.oculis.com
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG (FRA:CR5) Headlines

No Headlines